Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
India Globalization Capital, I - SIC # 7359 - EQUIPMENT RENTAL AND LEASING, NOT ELSEWHERE CLASSIFIED
Ticker
Exchange
SIC #
Website
Latest Ticker
IGC
American
7359
http://www.igcinc.us
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for India Globalization Capital, I
IGC Reports Financial Results for Fiscal Year Ended March 31, 2022
- Jun 23rd, 2022 3:26 am
IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate
- Jun 21st, 2022 4:15 am
IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders
- Jun 9th, 2022 1:03 am
India Globalization Capital, Inc. (IGC) Announces Final Approval of Settlement of Shareholder Class Action Lawsuits
- Apr 18th, 2022 9:28 pm
India Globalization Capital Appoints Claudia Grimaldi to its Board of Directors
- Mar 23rd, 2022 8:55 pm
IGC Reports Financial Results for the December 31, 2021 Quarter
- Feb 10th, 2022 9:30 pm
India Globalization Capital Appoints Former Congressman Jim Moran to Its Board of Directors
- Jan 19th, 2022 2:29 pm
Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug
- Dec 14th, 2021 2:25 pm
Phase 1 Clinical Trial Provides Valuable Insights on Safe and Effective Dosing of IGC-AD1 for Alzheimer’s Patients
- Dec 8th, 2021 10:43 pm
Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients
- Dec 2nd, 2021 2:32 pm
IGC Reports Financial Results for the September 30, 2021 Quarter
- Oct 30th, 2021 2:09 am
IGC Announces Results of its 2021 Annual Stockholders Meeting
- Oct 15th, 2021 8:00 pm
IGC Completes its Phase 1 Clinical Trial on Alzheimer’s Patients, Reports Safety and Tolerability
- Sep 7th, 2021 11:30 pm
IGC Reports Financial Results for the June 30, 2021, Quarter
- Aug 12th, 2021 12:00 am
IGC Announces Issuance of Patent for the Treatment of Alzheimer’s Disease Using THC
- Jul 22nd, 2021 11:00 am
Scroll